Welcome to our dedicated page for GLBLW news (Ticker: GLBLW), a resource for investors and traders seeking the latest updates and insights on GLBLW stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GLBLW's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GLBLW's position in the market.
Cartesian Growth Corporation announced the closing of its initial public offering of 34,500,000 units, raising $345 million at a price of $10.00 per unit. The offering included 4,500,000 units from the underwriters' over-allotment option. The units are listed on the Nasdaq under the ticker symbol GLBLU. Each unit consists of one Class A ordinary share and one-third of a warrant, exercisable at $11.50 per share. This capital aims to support the Company’s strategy to engage in business combinations with high-growth companies.
Cartesian Growth Corporation announced the pricing of its initial public offering (IPO) of 30,000,000 units at $10.00 each, increased from 25,000,000 units. Trading is set to begin on February 24, 2021, on Nasdaq under symbol GLBLU. Each unit consists of one Class A ordinary share and one-third of a redeemable warrant, with whole warrants convertible at $11.50. The offering is expected to close around February 26, 2021. Cantor Fitzgerald & Co. serves as the sole book-running manager, with a 45-day option for underwriters to purchase an additional 4,500,000 units.
